Atlas Trials

Evaluation of Prevalence and Risk Factors of Persistent COVID-19 in Immunocompromised Patients

Clinical trial NCT06576102 · COMPLETED

Trial details

NCT number
NCT06576102
Sponsor
Maddalena Giannella
Status
COMPLETED
Study type
OBSERVATIONAL
Persistent COVID-19B Cell Malignancies
Start date
2024-03-01
Primary completion
2024-09-30
Enrollment
204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.